DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

39.47 0.16 (0.41%)

Quote as of


company name or ticker

Recent Quotes

XLRN $39.47 0.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.79
Previous Close $39.31
Daily Range $38.79 - $41.31
52-Week Range $23.61 - $53.93
Market Cap $1.3B
P/E Ratio 27.88
Dividend (Yield) $0.00 (0.0%)
Volume 234,819
Average Daily Volume 283,997
Current FY EPS -$1.03

Sector

Industry

CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description

CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/

News & Commentary Rss Feed

Celgene Corp.'s Expanding Margins

But it wasn't all the healthy kind of expansion.

5 Cant-Miss Reasons Why Celgene Corporation Could Soar

Celgene Corporation has issued long-term guidance that suggests significant sales and profit growth through 2020.

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Insider Trading Alert - XLRN, MOH And PF Traded By Insiders

Insider Trading Alert - EXA, CVV And XLRN Traded By Insiders

5 Predictions for Biotechnology Stocks in 2015

Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.

Minerva Neurosciences' MIN-301 Positive in Primate Study - Analyst Blog

These 3 Biotechs Are Looking at a Happy New Year

Which drugs are poised to carry their makers into a healthy 2015? Industry Focus has three top picks.

Commit To Purchase Acceleron Pharma At $30, Earn 16.7% Annualized Using Options

Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6% - Tale of the Tape

See More XLRN News...